Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Wojciech Jurczak MD, PhD

Name: Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Wojciech Jurczak MD, PhD
Uploaded: 2026-05-24T03:43:00+0000
Duration: 1224 s
Description: Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Faculty Presentation 1: Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Newly Diagnosed and Relapsed/Refractory Chronic Lymphoc

Posted on 05/24/2026

20:24 |

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia | Faculty Presentation 1: Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Newly Diagnosed and Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) — Wojciech Jurczak MD, PhD

CME information and select publications